Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
Ioannis Katsoularis, Osvaldo Fonseca‐Rodríguez, Paddy Farrington, et al.
The Lancet (2021) Vol. 398, Iss. 10300, pp. 599-607
Open Access | Times Cited: 498

Showing 1-25 of 498 citing articles:

Long-term cardiovascular outcomes of COVID-19
Yan Xie, Evan Xu, Benjamin Bowe, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 583-590
Open Access | Times Cited: 1604
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
Julia Hippisley‐Cox, Martina Patone, Xue W. Mei, et al.
BMJ (2021), pp. n1931-n1931
Open Access | Times Cited: 316
Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study
Ioannis Katsoularis, Osvaldo Fonseca‐Rodríguez, Paddy Farrington, et al.
BMJ (2022), pp. e069590-e069590
Open Access | Times Cited: 307
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Suowen Xu, Iqra Ilyas, Jianping Weng
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 695-709
Open Access | Times Cited: 273
Understanding COVID-19-associated coagulopathy
Edward M. Conway, Nigel Mackman, Ronald Q. Warren, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 639-649
Open Access | Times Cited: 246
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
Rosemary Knight, Venexia Walker, Samantha Ip, et al.
Circulation (2022) Vol. 146, Iss. 12, pp. 892-906
Open Access | Times Cited: 220
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 4, pp. 537-559
Open Access | Times Cited: 210
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
Zahra Raisi‐Estabragh, Jackie A. Cooper, Ahmed Salih, et al.
Heart (2022) Vol. 109, Iss. 2, pp. 119-126
Open Access | Times Cited: 114
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study
Evangelos Oikonomou, Nektarios Souvaliotis, Stamatios Lampsas, et al.
Vascular Pharmacology (2022) Vol. 144, pp. 106975-106975
Open Access | Times Cited: 110
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 102
Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
Emma Rezel‐Potts, Abdel Douiri, Xiaohui Sun, et al.
PLoS Medicine (2022) Vol. 19, Iss. 7, pp. e1004052-e1004052
Open Access | Times Cited: 96
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
Gregory Y.H. Lip, Deirdre A. Lane, Radosław Lenarczyk, et al.
European Heart Journal (2022) Vol. 43, Iss. 26, pp. 2442-2460
Open Access | Times Cited: 80
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels
Natalia Eberhardt, María G. Noval, Ravneet Kaur, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 10, pp. 899-916
Open Access | Times Cited: 63
One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database
Andrea DeVries, Sonali Shambhu, Sue Sloop, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 3, pp. e230010-e230010
Open Access | Times Cited: 45
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
Peter J. Kelly, Peter Kelly, Peter Kelly, et al.
The Lancet (2024) Vol. 404, Iss. 10448, pp. 125-133
Closed Access | Times Cited: 34
Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System
George N. Ioannou, Aaron Baraff, Alexandra Fox, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2224359-e2224359
Open Access | Times Cited: 59
COVID-19 and the brain
Karan Hingorani, Shivkumar Bhadola, Anna M. Cervantes‐Arslanian
Trends in Cardiovascular Medicine (2022) Vol. 32, Iss. 6, pp. 323-330
Open Access | Times Cited: 57
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
Jérémie Botton, Marie-Joëlle Jabagi, Marion Bertrand, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1250-1257
Open Access | Times Cited: 48
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
Sokratis A. Apostolidis, Amrita Sarkar, H.M. Giannini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Neurological consequences of COVID-19
Waldemar Brola, Maciej Wilski
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1208-1222
Open Access | Times Cited: 41
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study
Celine Sze Ling Chui, Min Fan, Eric Yuk Fai Wan, et al.
EClinicalMedicine (2022) Vol. 50, pp. 101504-101504
Open Access | Times Cited: 40
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease
Xuxiao Ye, Tiantian Ma, Joseph E. Blais, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 10, pp. 2329-2338
Open Access | Times Cited: 37
SARS-CoV-2 and the nervous system: current perspectives
Amrita Pattanaik, Sushma Bhandarkar B, Lonika Lodha, et al.
Archives of Virology (2023) Vol. 168, Iss. 6
Open Access | Times Cited: 33
Clinical course and management of COVID-19 in the era of widespread population immunity
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 2, pp. 75-88
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top